All Stories

  1. SARS-CoV-2 Infection in Infants Less than 90 Days Old
  2. Return to School for Pediatric Solid Organ Transplant Recipients in the United States During the Coronavirus Disease 2019 Pandemic: Expert Opinion on Key Considerations and Best Practices
  3. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)
  4. Benign course of SARS‐CoV‐2 infection in a series of pediatric oncology patients
  5. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19)
  6. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy
  7. Utility of Metagenomic Next-generation Sequencing of Plasma for Infectious Pathogens
  8. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children
  9. Lessons about early neurodevelopment in children exposed to ZIKV in utero
  10. Non-invasive diagnosis of infection using plasma next-generation sequencing: A single center experience
  11. Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease
  12. Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections
  13. Outcomes of observation without empiric intravenous antibiotics in febrile, nonneutropenic pediatric oncology patients
  14. Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis
  15. Zika Virus: A Review for Pediatricians
  16. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage
  17. Preliminary Results From the US Zika Pregnancy Registry
  18. Treatment of perinatal viral infections to improve neurologic outcomes
  19. IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients
  20. The Type I Interferon Response Determines Differences in Choroid Plexus Susceptibility between Newborns and Adults in Herpes Simplex Virus Encephalitis
  21. HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain
  22. Aspergillusthyroiditis: first antemortem case diagnosed by fine-needle aspiration culture in a pediatric stem cell transplant patient
  23. Differential Reliance on Autophagy for Protection from HSV Encephalitis between Newborns and Adults
  24. Early viral suppression improves neurocognitive outcomes in HIV-infected children
  25. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT
  26. Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV
  27. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy
  28. The Immunologic Basis for Severe Neonatal Herpes Disease and Potential Strategies for Therapeutic Intervention
  29. Pathogenesis of Neonatal Herpes Simplex 2 Disease in a Mouse Model Is Dependent on Entry Receptor Expression and Route of Inoculation
  30. Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance
  31. Herpes Simplex Virus-2 Glycoprotein Interaction with HVEM Influences Virus-Specific Recall Cellular Responses at the Mucosa
  32. Functional Interaction between Herpes Simplex Virus Type 2 gD and HVEM Transiently Dampens Local Chemokine Production after Murine Mucosal Infection
  33. Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
  34. Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection
  35. Recombinant Listeria monocytogenes expressing an immunodominant peptide fails to protect after intravaginal challenge with herpes simplex virus-2
  36. Clinical and In Vitro Evaluation of Cidofovir for Treatment of Adenovirus Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients
  37. Group Aβ-hemolytic Streptococcal Vulvovaginitis: Diagnosis by Rapid Antigen Testing
  38. A Strategy for the Evaluation of Sensory and Pulmonary Irritation Due to Chemical Emissions from Indoor Sources
  39. Sensory Irritation in Mice Exposed to Emissions from Indoor Products
  40. Pathways for uptake of fluorescently labeled liposomes by alveolar type II cells in culture
  41. A Model of Cigarette Smoke Particle Deposition
  42. Studies of wall shear and mass transfer in a large scale model of neonatal high-frequency jet ventilation
  43. Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation